{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:59:16Z","timestamp":1790189956621,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:p>This observational study aimed to compare various genotyping and enrichment platforms to determine the most comprehensive coverage for genome-wide association studies, specifically targeting new therapeutic approaches against coronaviruses using chloroquine. Pharmacogenomic studies have become essential for understanding individual drug responses, and optimal platform selection is critical for identifying relevant genetic variants. We developed Python scripts to assess the coverage rates of these platforms, focusing on the absorption, distribution, metabolism, and excretion (ADME) genes involved in drug absorption, distribution, metabolism, and excretion. Additionally, the PLINK tool was employed to evaluate single nucleotide polymorphisms in linkage disequilibrium with ADME variants, providing insights into the extended coverage achieved through correlation with these variants. Among the genotyping platforms analyzed, Axiom genotyping and SureSelect enrichment platforms demonstrated the most extensive coverage of the genome and key pharmacogenomic regions. These platforms effectively captured a significant proportion of ADME gene variants, which are crucial for predicting individual responses to chloroquine. The extensive coverage provided by the Axiom and SureSelect platforms supports their use in the design of pharmacogenomic studies, potentially revealing new therapeutic targets for combating coronaviruses, including through the use of chloroquine treatment. The results highlight the importance of selecting appropriate genotyping and enrichment technologies for maximizing the impact of pharmacogenomic research.<\/jats:p>","DOI":"10.1097\/md.0000000000044340","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:11Z","timestamp":1757970011000},"page":"e44340","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Assessing ADME gene coverage: An observational study on chloroquine therapy for COVID-19"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9272-6591","authenticated-orcid":false,"given":"Nabil","family":"Zaid","sequence":"first","affiliation":[{"name":"Higher Institute of Nursing and Health Technical Professions (ISPITS), Rabat \u2013 Ministry of Health and Social Protection, Rabat, Morocco"},{"name":"Biology Department, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamyaa","family":"Benchikhi","sequence":"additional","affiliation":[{"name":"Higher Institute of Nursing and Health Technical Professions (ISPITS), Rabat \u2013 Ministry of Health and Social Protection, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"El Abboudi","sequence":"additional","affiliation":[{"name":"Higher Institute of Nursing and Health Technical Professions (ISPITS), Rabat \u2013 Ministry of Health and Social Protection, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubna","family":"Khalki","sequence":"additional","affiliation":[{"name":"Research Center, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oussama","family":"Badad","sequence":"additional","affiliation":[{"name":"Southern Illinois University, Carbondale, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youness","family":"Limami","sequence":"additional","affiliation":[{"name":"Research Center of Abulcasis University of Health Sciences, Rabat, Morocco"},{"name":"Immunology and Biodiversity Laboratory, Department of Biology, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Naya","sequence":"additional","affiliation":[{"name":"Immunology and Biodiversity Laboratory, Department of Biology, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounia","family":"Oudghiri","sequence":"additional","affiliation":[{"name":"Immunology and Biodiversity Laboratory, Department of Biology, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banacer","family":"Himmi","sequence":"additional","affiliation":[{"name":"Higher Institute of Nursing and Health Technical Professions (ISPITS), Rabat \u2013 Ministry of Health and Social Protection, Rabat, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Zaid","sequence":"additional","affiliation":[{"name":"Biology Department, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco"},{"name":"Immunology and Biodiversity Laboratory, Department of Biology, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.ijantimicag.2020.105923","article-title":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2.","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State.","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrg.2016.86","article-title":"Towards precision medicine.","volume":"17","author":"Ashley","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"e13975","DOI":"10.1097\/MD.0000000000013975","article-title":"Coverage rate of ADME genes from commercial sequencing arrays.","volume":"98","author":"Zaid","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2217\/pgs-2017-0129","article-title":"Pharmacogenetic content of commercial genome-wide genotyping arrays.","volume":"19","author":"Lemieux Perreault","year":"2018","journal-title":"Pharmacogenomics"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic.","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"R10-20260923","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd4581","article-title":"Predicting drug metabolism: experiment and\/or computation?","volume":"14","author":"Kirchmair","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R11-20260923","first-page":"321","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2B6 and efavirenz-containing antiretroviral therapy.","volume":"108","author":"Desta","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.","volume":"133","author":"Fan","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods.","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"key":"R14-20260923","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygeno.2011.04.005","article-title":"Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array.","volume":"98","author":"Hoffmann","year":"2011","journal-title":"Genomics"},{"key":"R15-20260923","first-page":"1","article-title":"Abstracts from the 51st European Society of Human Genetics Conference: posters.","volume":"27","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00125-012-2756-1","article-title":"Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes.","volume":"56","author":"Albrechtsen","year":"2013","journal-title":"Diabetologia"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/FPC.0000000000000260","article-title":"Characterization of ADME gene variation in 21 populations by exome sequencing.","volume":"27","author":"Hovelson","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.mayocp.2017.09.001","article-title":"Pharmacogenomics: precision medicine and drug response.","volume":"92","author":"Weinshilboum","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ht9020008","article-title":"DMETTM genotyping: tools for biomarkers discovery in the era of precision medicine.","volume":"9","author":"Agapito","year":"2020","journal-title":"High Throughput"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:00:51Z","timestamp":1790186451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":19,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044340","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"2024-10-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}